News for Trevena, Inc. (6T4.F)

Published at

Feb 19, 2021 1:00 PM

by markets.businessinsider.com

mixed

mixed

Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors

PHILADELPHIA, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformati...

PASG AX9.MU AX9.F AX9.BE AKBA ACRS 8AT.MU 8AT.F 8AT.BE TRVN IDRA HXXB.F HXXB.BE 6T4.MU 6T4.F 6T4.BE

Read more →
Published at

Feb 11, 2021 11:01 PM

by sec.gov

neutral

neutral

EDGAR Filing Documents for 0001104659-21-020782

Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 61035488...

TRVN 6T4.MU 6T4.F 6T4.BE

Read more →
Published at

Jan 7, 2021 1:00 PM

by benzinga.com

positive

positive

Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and ...

TRVN 6T4.MU 6T4.F 6T4.BE

Read more →
Published at

Jan 6, 2021 1:00 PM

by benzinga.com

positive

positive

Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts

-- Build-out of customer-facing team on track for this quarter OLINVYK comprehensive product dossier / health economic model now available to facilitate ...

TRVN 6T4.MU 6T4.F 6T4.BE

Read more →